Advancing imaging biomarker development and translation through the National Cancer Imaging Translational Accelerator (NCITA)

The NCITA consortium aims to provide researchers with the infrastructure to conduct high-quality clinical research in the pursuit of standardised imaging biomarkers, and translating this into clinical settings for the early diagnosis and treatment of cancer

It is estimated that someone is diagnosed with cancer every two minutes in the UK. Clinical imaging offers a minimally invasive way of diagnosing and managing a variety of cancers. The National Cancer Imaging Translational Accelerator (NCITA) consortium now provides researchers with the infrastructure to conduct high-quality, multi-centre clinical research in the quest to develop standardised imaging biomarkers and accelerate […]

Read More… from Advancing imaging biomarker development and translation through the National Cancer Imaging Translational Accelerator (NCITA)

Seeing the structures of molecules: insights from NMR and industry

Professor Anthony Serianni's work centres around identifying the structure of molecules, which remains a key challenge within modern chemistry.

Many of the essential chemical constituents of life, including carbohydrates, are made up of complex atomic arrangements. Knowing the particular structure of a compound is important not only for identification purposes, but also for understanding how biologically relevant compounds react. Through this knowledge, their biological functions can ultimately be deciphered. Professor Anthony Serianni at the University of Notre Dame has […]

Read More… from Seeing the structures of molecules: insights from NMR and industry